Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis

Por Xue, A, Scarlett, C J, Chung, L, Butturini, G, Scarpa, A, Gandy, R, Wilson, S R, Baxter, R C, Smith, R C
Publicado em 2010

Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma

Por Murphy, N C, Scarlett, C J, Kench, J G, Sum, E Y M, Segara, D, Colvin, E K, Susanto, J, Cosman, P H, Lee, C-S, Musgrove, E A, Sutherland, R L, Lindeman, G J, Henshall, S M, Visvader, J E, Biankin, A V
Publicado em 2008

The prognostic and predictive value of serum CA19.9 in pancreatic cancer

Por Humphris, J. L., Chang, D. K., Johns, A. L., Scarlett, C. J., Pajic, M., Jones, M. D., Colvin, E. K., Nagrial, A., Chin, V. T., Chantrill, L. A., Samra, J. S., Gill, A. J., Kench, J. G., Merrett, N. D., Das, A., Musgrove, E. A., Sutherland, R. L., Biankin, A. V.
Publicado em 2012

Adjuvant chemotherapy in elderly patients with pancreatic cancer

Por Nagrial, A M, Chang, D K, Nguyen, N Q, Johns, A L, Chantrill, L A, Humphris, J L, Chin, V T, Samra, J S, Gill, A J, Pajic, M, Pinese, M, Colvin, E K, Scarlett, C J, Chou, A, Kench, J G, Sutherland, R L, Horvath, L G, Biankin, A V
Publicado em 2014

The histone deacetylase SIRT2 stabilizes Myc oncoproteins

Por Liu, P Y, Xu, N, Malyukova, A, Scarlett, C J, Sun, Y T, Zhang, X D, Ling, D, Su, S-P, Nelson, C, Chang, D K, Koach, J, Tee, A E, Haber, M, Norris, M D, Toon, C, Rooman, I, Xue, C, Cheung, B B, Kumar, S, Marshall, G M, Biankin, A V, Liu, T
Publicado em 2013